107 related articles for article (PubMed ID: 25651308)
1. Coaggregates of Regulatory T Cells and Islet Cells Allow Long-term Graft Survival in Liver Without Immunosuppression.
Takemoto N; Konagaya S; Kuwabara R; Iwata H
Transplantation; 2015 May; 99(5):942-7. PubMed ID: 25651308
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of co-aggregates of Sertoli cells and islet cells into liver without immunosuppression.
Takemoto N; Liu X; Takii K; Teramura Y; Iwata H
Transplantation; 2014 Feb; 97(3):287-93. PubMed ID: 24342973
[TBL] [Abstract][Full Text] [Related]
3. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.
Wu DC; Hester J; Nadig SN; Zhang W; Trzonkowski P; Gray D; Hughes S; Johnson P; Wood KJ
Transplantation; 2013 Oct; 96(8):707-16. PubMed ID: 23917725
[TBL] [Abstract][Full Text] [Related]
5. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
[TBL] [Abstract][Full Text] [Related]
6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
7. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
8. Effect of glucose toxicity on intraportal tilapia islet xenotransplantation in nude mice.
Al-Jazaeri A; Xu BY; Yang H; Macneil D; Leventhal JR; Wright JR
Xenotransplantation; 2005 May; 12(3):189-96. PubMed ID: 15807769
[TBL] [Abstract][Full Text] [Related]
9. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
[TBL] [Abstract][Full Text] [Related]
10. Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression.
Wang X; Hao J; Leung G; Breitkopf T; Wang E; Kwong N; Akhoundsadegh N; Warnock GL; Shapiro J; McElwee KJ
J Immunol Res; 2015; 2015():607328. PubMed ID: 26000314
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting islet graft embolization in the liver of diabetic mice.
Sakata N; Obenaus A; Chan N; Mace J; Chinnock R; Hathout E
Islets; 2009; 1(1):26-33. PubMed ID: 21084846
[TBL] [Abstract][Full Text] [Related]
12. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand.
Yao M; Watanabe M; Sun S; Tokodai K; Cerami A; Brines M; Östenson CG; Ericzon BG; Lundgren T; Kumagai-Braesch M
Transplantation; 2020 Oct; 104(10):2048-2058. PubMed ID: 32345869
[TBL] [Abstract][Full Text] [Related]
14. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
[TBL] [Abstract][Full Text] [Related]
15. Engraftment versus immunosuppression: cost-benefit analysis of immunosuppression after intrahepatic murine islet transplantation.
Marzorati S; Melzi R; Citro A; Cantarelli E; Mercalli A; Scavini M; Piemonti L
Transplantation; 2014 May; 97(10):1019-26. PubMed ID: 24770621
[TBL] [Abstract][Full Text] [Related]
16. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.
Stepkowski SM; Phan T; Zhang H; Bilinski S; Kloc M; Qi Y; Katz SM; Rutzky LP
Transplantation; 2006 Dec; 82(12):1756-63. PubMed ID: 17198272
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation.
Teramura Y; Iwata H
Transplantation; 2009 Sep; 88(5):624-30. PubMed ID: 19741458
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity and neurovascular integration of intraportally transplanted islets revealed by 3-D mouse liver histology.
Chen CC; Peng SJ; Wu PY; Chien HJ; Lee CY; Chung MH; Tang SC
Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1007-E1019. PubMed ID: 33900850
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatocyte-rich liver cell mixture and liver fibroblasts on prolonging graft islet survival in rats without immunosuppressive drugs.
Soto-Montenegro L; Zugasti-Murillo A; Rollán E; Alvarez Y; Alvarez G; Jara-Albarrán A
Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):580-6. PubMed ID: 15578333
[TBL] [Abstract][Full Text] [Related]
20. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
